Pfizer CEO Albert Bourla on Q3 earnings, patent expirations, obesity drug market
0:00 · Watch on YouTube
Pfizer CEO Albert Bourla argues that low COVID revenue is no longer a drag, that acquired products and heavy post-COVID deal spending can offset patent losses and return the company to high-single-digit growth after 2...